Loading stock data…
EVH
$3.79+0.04 (+1.07%)
Market OpenUpdated 1:04 PM EDT
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Evolent Health, Inc. in the Healthcare sector is trading at $3.88. The stock is currently near its 52-week low of $2.10, remaining 29.5% below its 200-day moving average. Technical signals show overbought RSI of 82 and bullish MACD crossover, explaining why EVH maintains its current current market pressure. The Whystock Score of 10/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Overbought levels (RSI 82) — risk of consolidation or pullback
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$3.79
Potential Upside
5%
Whystock Fair Value$3.98
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administratio...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$341.61M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.37
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-128.74%
Volume
Today's trading volume
866,651
Recent News
Why Evolent Health (EVH) Stock Is Up Today
Shares of healthcare solutions company Evolent Health (NYSE:EVH) jumped 4.1% in the afternoon session after the company reported fourth-quarter results that beat analyst earnings expectations and provided strong full-year revenue guidance.
Spotting Winners: Evolent Health (NYSE:EVH) And Healthcare Technology for Providers Stocks In Q4
Looking back on healthcare technology for providers stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Evolent Health (NYSE:EVH) and its peers.
ELV Q1 Deep Dive: Operating Discipline and AI Integration Drive Margin Expansion
Health insurance provider Elevance Health (NYSE:EVH) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 2.9% year on year to $50.18 billion. Its non-GAAP profit of $12.58 per share was 16.4% above analysts’ consensus estimates.
Elevance Health (NYSE:ELV) Reports Strong Q1 CY2026
Health insurance provider Elevance Health (NYSE:EVH) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 2.9% year on year to $50.18 billion. Its non-GAAP profit of $12.58 per share was 16.4% above analysts’ consensus estimates.
Elevance Health (ELV) Reports Q1: Everything You Need To Know Ahead Of Earnings
Health insurance provider Elevance Health (NYSE:EVH) will be reporting results this Wednesday morning. Here’s what to look for.